Aim: The executive summary of the American College of Cardiology/American Heart
Association/Society for Cardiovascular Angiography and Interventions coronary artery …

Heart failure (HF) has been recognized as a common complication of diabetes, with a
prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data …

Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

Summary Background The Synergy between PCI with Taxus and Cardiac Surgery
(SYNTAX) trial was a non-inferiority trial that compared percutaneous coronary intervention …

Background Randomised controlled trials are considered the gold standard for testing the
efficacy of novel therapeutic interventions, and typically report the average treatment effect …

Although cardiologists have long treated patients with coronary artery disease (CAD) and
concomitant type 2 diabetes mellitus (T2DM), T2DM has traditionally been considered just a …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Background Myocardial revascularization has been advocated to improve myocardial
function and prognosis in ischemic cardiomyopathy (ICM). We discuss the evidence for …

Background There remains a paucity of real-world observational evidence comparing
percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) in …